Skip to main content
SYNTARA LIMITED logo

SYNTARA LIMITED — Investor Relations & Filings

Ticker · SNT ISIN · AU0000312480 LEI · 52990054L6XWT345FW20 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,620 across all filing types
Latest filing 2006-09-24 AGM Information
Country AU Australia
Listing ASX SNT

About SYNTARA LIMITED

https://syntaratx.com.au/

Syntara Limited is a clinical-stage drug development company focused on the discovery and development of novel small molecule therapeutics for inflammatory and fibrotic diseases. The company specializes in the inhibition of amine oxidase enzymes, including lysyl oxidase (LOX) and semicarbazide-sensitive amine oxidase (SSAO). Its primary clinical focus is on hematological malignancies and multi-organ fibrosis. The lead drug candidate, PXS-5505, is a pan-LOX inhibitor currently being evaluated for the treatment of myelofibrosis. Additionally, the company develops treatments for skin scarring, pulmonary fibrosis, and neurodegenerative conditions. Syntara leverages its proprietary drug discovery platform to address significant unmet medical needs through targeted enzymatic inhibition, aiming to modify disease progression in complex pathological environments.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting 2006 15 pages ?Kb
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting' and details the agenda for the AGM of Pharmaxis Ltd, including items such as receiving the financial statements, remuneration report, re-election of directors, and approval of options grants to directors. It includes procedural information about voting, proxies, and explanatory notes related to the AGM agenda items. There is no actual financial data or report content included, only notice and agenda for the meeting. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document length is substantial but it is clearly a notice and agenda, not the full annual report or financial statements themselves.
2006-09-24 English
2006 Annual Report 108 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2006' and contains detailed sections typical of an annual report, including a Chairman's Review, mission statement, product pipeline, clinical trial updates, financial milestones, and corporate governance information. It discusses the company's operations, clinical progress, regulatory approvals, capital raising, and board changes. The length is substantial (15,000 characters), and the content includes comprehensive financial and operational details rather than just an announcement or summary. There is no indication that this is merely a notice or certification. Therefore, this document fits the definition of an Annual Report (10-K).
2006-09-24 English
2006 Annual Report 108 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2006' and contains detailed information about the company's mission, product pipeline, clinical trials, milestones, financial capital raising, and a chairman's review. It includes comprehensive narrative and data about the company's operations and achievements over the fiscal year 2006. The length is substantial (15,000 characters), and the content is consistent with a full annual report rather than a brief announcement or presentation. There is no indication that this is merely a notice or summary pointing to another report. Therefore, this document fits the definition of an Annual Report (10-K). FY 2006
2006-09-24 English
Board Change 2 pages ?Kb
Board/Management Information Classification · 100% confidence The document is a media release dated 22 September 2006 announcing a change in the board of directors of Pharmaxis Ltd. It specifically states that Ms Brigitte Smith will not seek re-election and will retire by rotation at the upcoming Annual General Meeting. The content focuses on the board transition and the independence of directors. There is no financial data, no mention of a report being attached or published, and no regulatory certification. The document fits the category of announcements related to changes in the company's board of directors or senior management.
2006-09-21 English
Appendix 3B - Issue of Employee Options 9 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) announcement used for new issue announcements, applications for quotation of additional securities, and agreements related to securities issuance. It details the issuance of unlisted employee options, exercise prices, expiry dates, and the number of securities issued. The document is regulatory in nature, providing information about securities issuance rather than financial results or management commentary. It does not contain financial statements or detailed financial analysis, nor is it a report or presentation. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2006-09-19 English
Appendix 3B 10 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B' and is an announcement related to the issue of new securities, specifically ordinary shares issued upon exercise of options under an employee option plan. It includes details such as the number of securities issued, issue price, purpose of the issue, and dates related to the securities. Appendix 3B is a standard form used in Australian Securities Exchange (ASX) announcements for new issue announcements and applications for quotation of additional securities. This document is not a full financial report, earnings release, or management discussion, but rather a capital/financing update regarding share issuance. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length and content support a high confidence in this classification.
2006-09-03 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.